1371608-92-2

Upstream product

• 60702-69-4 2-chloro-4-fluorobenzonitrile 
• 684-93-5 1-methyl-1-nitrosourea 
• 1371608-91-1 (R)-2-(3-chloro-4-cyanophenylamino)-3-hydroxypropanoic acid 

Downstream Products

• 1371608-41-1 2-chloro-4-((R)-2-oxo-4-((S)-2,2,2-trifluoro-1-hydroxyethyl)oxazolidin-3-yl)benzonitrile 
• 1371608-42-2 2-chloro-4-((R)-2-oxo-4-((R)-2,2,2-trifluoro-1-hydroxyethyl)oxazolidin-3-yl)benzonitrile 
• 1371608-95-5 C₁₁H₇ClN₂O₃ 
• 1371608-94-4 (S)-2-chloro-4-(4-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzonitrile 

Relevant academic research and scientific papers

SELECTIVE ANDROGEN RECEPTOR MODULATORS

This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.